DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 11, Pages 2657
Publisher
MDPI AG
Online
2019-05-30
DOI
10.3390/ijms20112657
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Noninvasive Detection of High Grade Prostate Cancer by DNA Methylation Analysis of Urine Cells Captured by Microfiltration
- (2018) Louise Katrine Larsen et al. JOURNAL OF UROLOGY
- Analysis of DNA methylation in cancer: location revisited
- (2018) Alexander Koch et al. Nature Reviews Clinical Oncology
- Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study
- (2018) Run-Qi Guo et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Evaluation of Urinary DNA Methylation as a Marker for Recurrent Bladder Cancer: A 2-Center Prospective Study
- (2018) Tetsuya Shindo et al. UROLOGY
- Promoter methylation analysis of CDH1 and p14ARF genes in patients with urothelial bladder cancer
- (2018) Bayram Bayramov et al. OncoTargets and Therapy
- The diagnostic accuracy of methylation markers in urine for the detection of bladder cancer: a systematic review
- (2018) Judith Bosschieter et al. Epigenomics
- Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer
- (2018) Jolein Mijnes et al. Clinical Epigenetics
- Urine cell-based DNA methylation classifier for monitoring bladder cancer
- (2018) Antoine G. van der Heijden et al. Clinical Epigenetics
- A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA
- (2018) Igor Brikun et al. Clinical Epigenetics
- A protocol for urine collection and storage prior to DNA methylation analysis
- (2018) J. Bosschieter et al. PLoS One
- Current and future perspectives of liquid biopsies in genomics-driven oncology
- (2018) Ellen Heitzer et al. NATURE REVIEWS GENETICS
- A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer
- (2018) Fang Zhao et al. Clinical Epigenetics
- Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients
- (2018) Catarina Moreira-Barbosa et al. Clinical Epigenetics
- Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer
- (2018) Sebastian Stasik et al. CLINICAL BIOCHEMISTRY
- Comparative analysis of 12 different kits for bisulfite conversion of circulating cell-free DNA
- (2017) Mai-Britt Worm Ørntoft et al. Epigenetics
- MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors
- (2017) Jorge Torres-Ferreira et al. Molecular Cancer
- Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer
- (2016) Jean-Pierre Roperch et al. BMC CANCER
- A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross Hematuria
- (2016) Christina M. Dahmcke et al. EUROPEAN UROLOGY
- Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria
- (2016) Kim E.M. van Kessel et al. JOURNAL OF UROLOGY
- Quantitative comparison of DNA methylation assays for biomarker development and clinical applications
- (2016) Christoph Bock et al. NATURE BIOTECHNOLOGY
- Clinical potential of TCF21 methylation in the diagnosis of renal cell carcinoma
- (2016) Jun Xin et al. Oncology Letters
- Experimental factors affecting the robustness of DNA methylation analysis
- (2016) Heidi D. Pharo et al. Scientific Reports
- DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer
- (2015) Lian Zhang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer
- (2015) Joseph J. Fantony et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Identification of specific DNA methylation sites on the Y-chromosome as biomarker in prostate cancer
- (2015) Lushuai Yao et al. Oncotarget
- Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma
- (2015) Chia-Ming Yeh et al. Oncotarget
- An epigenetic biomarker combination of PCDH17 and POU4F2 detects bladder cancer accurately by methylation analyses of urine sediment DNA in Han Chinese
- (2015) Yongqiang Wang et al. Oncotarget
- Filtration Device for On-Site Collection, Storage and Shipment of Cells from Urine and Its Application to DNA-Based Detection of Bladder Cancer
- (2015) Elin Andersson et al. PLoS One
- Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine
- (2015) Masamichi Hayashi et al. Oncotarget
- An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine
- (2015) Leonel Maldonado et al. Oncotarget
- A Panel of Three Markers Hyper- and Hypomethylated in Urine Sediments Accurately Predicts Bladder Cancer Recurrence
- (2014) S.-F. Su et al. CLINICAL CANCER RESEARCH
- Prognostic Value of RASSF1 Promoter Methylation in Prostate Cancer
- (2014) Kristina Daniunaite et al. JOURNAL OF UROLOGY
- Size-Based Enrichment of Exfoliated Tumor Cells in Urine Increases the Sensitivity for DNA-Based Detection of Bladder Cancer
- (2014) Elin Andersson et al. PLoS One
- Novel Multiplex MethyLight Protocol for Detection of DNA Methylation in Patient Tissues and Bodily Fluids
- (2014) Ekaterina Olkhov-Mitsel et al. Scientific Reports
- Diagnostic markers of urothelial cancer based on DNA methylation analysis
- (2013) Yoshitomo Chihara et al. BMC CANCER
- A 3-Plex Methylation Assay Combined with the FGFR3 Mutation Assay Sensitively Detects Recurrent Bladder Cancer in Voided Urine
- (2013) R. Kandimalla et al. CLINICAL CANCER RESEARCH
- Hypermethylation of TWIST1 and NID2 in Tumor Tissues and Voided Urine in Urinary Bladder Cancer Patients
- (2013) Zeynep Yegin et al. DNA AND CELL BIOLOGY
- A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urine
- (2013) Marc Birkhahn et al. EUROPEAN JOURNAL OF CANCER
- Molecular Detection of Prostate Cancer by Methylation-Specific Polymerase Chain Reaction from Urine Specimens
- (2013) Raluca Dumache et al. Journal of Medical Biochemistry
- Methylation of a Novel Panel of Tumor Suppressor Genes in Urine Moves Forward Noninvasive Diagnosis and Prognosis of Bladder Cancer: A 2-Center Prospective Study
- (2013) Rodrigo García-Baquero et al. JOURNAL OF UROLOGY
- DNA methylation-based biomarkers in bladder cancer
- (2013) Raju Kandimalla et al. Nature Reviews Urology
- The Use of Molecular Analyses in Voided Urine for the Assessment of Patients with Hematuria
- (2013) Willemien Beukers et al. PLoS One
- Clinical performance and utility of a DNA methylation urine test for bladder cancer11This study was funded, in part, by MDxHealth (formerly OncoMethlyome Sciences).
- (2013) Michael R. Abern et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Urinary retinoic acid receptor-β2 gene promoter methylation and hyaluronidase activity as noninvasive tests for diagnosis of bladder cancer
- (2012) Sanaa Eissa et al. CLINICAL BIOCHEMISTRY
- Methylation of a Panel of MicroRNA Genes Is a Novel Biomarker for Detection of Bladder Cancer
- (2012) Takashi Shimizu et al. EUROPEAN UROLOGY
- Detecting DNA Methylation of the BCL2, CDKN2A and NID2 Genes in Urine Using a Nested Methylation Specific Polymerase Chain Reaction Assay to Predict Bladder Cancer
- (2012) Michael B. Scher et al. JOURNAL OF UROLOGY
- Combinations of Urinary Biomarkers for Surveillance of Patients with Incident Nonmuscle Invasive Bladder Cancer: The European FP7 UROMOL Project
- (2012) Tahlita C.M. Zuiverloon et al. JOURNAL OF UROLOGY
- A Noninvasive Multianalyte Urine-Based Diagnostic Assay for Urothelial Cancer of the Bladder in the Evaluation of Hematuria
- (2012) R. Jeffrey Karnes et al. MAYO CLINIC PROCEEDINGS
- Methylcap-Seq Reveals Novel DNA Methylation Markers for the Diagnosis and Recurrence Prediction of Bladder Cancer in a Chinese Population
- (2012) Yangxing Zhao et al. PLoS One
- Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation
- (2012) Thomas Reinert et al. PLoS One
- A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine
- (2011) Tahlita C.M. Zuiverloon et al. BJU INTERNATIONAL
- Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine
- (2011) Pi-Che Chen et al. BMC Medical Genomics
- Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments
- (2011) W. Chung et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Aberrant Methylation of RAR 2 and APC Genes in Voided Urine as Molecular Markers for Early Detection of Bilharzial and Nonbilharzial Bladder Cancer
- (2011) S. Eissa et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers
- (2011) T. Reinert et al. CLINICAL CANCER RESEARCH
- TCF21andPCDH17methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers
- (2011) Vera L. Costa et al. Epigenetics
- Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples
- (2010) V. L. Costa et al. CLINICAL CANCER RESEARCH
- Integrated genetic and epigenetic analysis of bladder cancer reveals an additive diagnostic value of FGFR3 mutations and hypermethylation events
- (2010) Reza R. Serizawa et al. INTERNATIONAL JOURNAL OF CANCER
- Use of a combination of biomarkers in serum and urine to improve detection of prostate cancer
- (2010) Celia Prior et al. WORLD JOURNAL OF UROLOGY
- Identification and Validation of the Methylated TWIST1 and NID2 Genes through Real-Time Methylation-Specific Polymerase Chain Reaction Assays for the Noninvasive Detection of Primary Bladder Cancer in Urine Samples
- (2009) Isabelle Renard et al. EUROPEAN UROLOGY
- Hypermethylated SFRP1, but none of other nine genes “informative” for western countries, is valuable for bladder cancer detection in mainland China
- (2009) Jinfeng Sun et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Multicenter Evaluation of an Investigational Prostate Cancer Methylation Assay
- (2009) Jonathan Baden et al. JOURNAL OF UROLOGY
- DNA methylation biomarkers of prostate cancer: Confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection
- (2009) Shannon R. Payne et al. PROSTATE
- Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-cadherin, p16, p14, RASSF1A genes in urine
- (2009) Hui-Hui Lin et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Quantitative methylation analysis of BCL2, hTERT, and DAPK promoters in urine sediment for the detection of non-muscle-invasive urothelial carcinoma of the bladder: A prospective, two-center validation study
- (2009) Serena Vinci et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis
- (2008) Morgan Rouprêt et al. BJU INTERNATIONAL
- Development of a Multiplexed Urine Assay for Prostate Cancer Diagnosis
- (2008) T. Vener et al. CLINICAL CHEMISTRY
- The Usefulness of the Detection of GSTP1 Methylation in Urine as a Biomarker in the Diagnosis of Prostate Cancer
- (2008) Karen Woodson et al. JOURNAL OF UROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started